Intellia Therapeutics(NTLA)
$9.52-0.25 (-2.56%)
NTLA
Intellia Therapeutics earnings date
$9.52
At close:-0.25 (-2.56%)
Want to see NTLA full AI Analyst Report?
Intellia Therapeutics (NTLA) Q2 2025 Earnings Report
4,936 Followers
NTLA Q2 2025 EPS Results
- Actual EPS
- -$0.98
- Consensus EPS
- -$1.02
- Beat/Miss
- Beat by +$0.04
- One Year Ago EPS
- -$1.52
NTLA Q2 2025 Revenue Results
- Actual Revenue
- $14.24M
- Expected Revenue
- $11.89M
- Beat/Miss
- Beat by +$2.36M
- YoY Revenue Growth
- +104.76%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/07/2025
- Time
- Before Open
- Conference Call
- Thursday, August 7, 2025
NTLA Upcoming Earnings
Intellia Therapeutics's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
NTLA Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
NTLA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.79- | -0.83 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.80-0.91 | -0.92 | 1.09% (+0.01) | |
| Aug 06, 2026 | 2026 (Q2) | -0.80-0.80 | -0.98 | 18.37% (+0.18) | |
| May 11, 2026 | 2026 (Q1) | -0.91-0.81 | -1.1 | 26.36% (+0.29) | |
| Feb 26, 2026 | 2025 (Q4) | -0.95-0.83 | -1.27 | 34.65% (+0.44) | |
| Nov 06, 2025 | 2025 (Q3) | -1.00-0.92 | -1.34 | 31.34% (+0.42) | |
| Aug 07, 2025 | 2025 (Q2) | -1.02-0.98 | -1.52 | 35.53% (+0.54) | |
| May 08, 2025 | 2025 (Q1) | -1.28-1.10 | -1.12 | 1.79% (+0.02) | |
| Feb 27, 2025 | 2024 (Q4) | -1.33-1.27 | -1.46 | 13.01% (+0.19) | |
| Nov 07, 2024 | 2024 (Q3) | -1.39-1.34 | -1.38 | 2.90% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

